Xuan Ma

Xuan Ma

Auto-generated profile, based on publicly available information

Xuan Ma

Department of Radiology, Fuwai Hospital, National Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2023 in European Heart Journal
Verified
Journal Article
Open access
PDF file
JWJiaxin Wang
Jiaxin Wang
SYShujuan Yang
Shujuan Yang
XMXuan Ma
Xuan Ma
KZKankan Zhao
Kankan Zhao
KYKai Yang
Kai Yang
SZShihua Zhao
Shihua Zhao
Identifying patients with hypertrophic cardiomyopathy (HCM) who are candidates for implantable cardioverter defibrillator (ICD) implantation in primary prevention for sudden cardiac death (SCD) is crucial. The aim of this study was to externally validate the 2022 European Society of Cardiology (ESC) model and other guideline-based ICD class of recommendation (ICD-COR) models and explore the utility of late gadolinium enhancement (LGE) in further risk stratification. Seven hundred and seventy-four consecutive patients who underwent cardiac magnetic resonance imaging were retrospectively enrolled. Forty-six (5.9%) patients reached the SCD-related endpoint during 7.4 ± 2.5 years of follow-up. Patients suffering from SCD had higher ESC Risk-SCD score (4.3 ± 2.4% vs. 2.8 ± 2.1%, P < .001) and LGE extent (13.7 ± 9.4% vs. 4.9 ± 6.6%, P < .001). Compared with the 2014 ESC model, the 2022 ESC model showed increased area under the curve (.76 vs. .63), sensitivity (76.1% vs. 43.5%), positive predictive value (16.8% vs. 13.6%), and negative predictive value (98.1% vs. 95.9%). The C-statistics for SCD prediction of 2011 American College of Cardiology (ACC)/American Heart Association (AHA), 2014 ESC, 2020 AHA/ACC, and 2022 ESC models were .68, .64, .76 and .78, respectively. Furthermore, in patients without extensive LGE, LGE ≥5% was responsible for seven-fold SCD risk after multivariable adjustment. Whether in ICD-COR II or ICD-COR III, patients with LGE ≥5% and <15% showed significantly worse prognosis than those with LGE <5% (all P < .001). The 2022 ESC model performed better than the 2014 ESC model with especially improved sensitivity. LGE enabled further risk stratification based on current guidelines. In a sizable Chinese cohort of 774 patients with hypertrophic cardiomyopathy, 46 (5.9%) patients suffered SCD events during a mean follow-up of 7.4 years. The new 2022 ESC model performed better than 2014 ESC model for SCD risk stratification with increased C-statistics from 0.64 to 0.78 and especially improved sensitivity from 43.5% to 76.1%. 2022 ESC model and 2020 AHA/ACC model showed similar overall discrimination performance. LGE with a cut-off of 5% enabled further risk stratification based on current 2022 ESC and 2020 AHA/ACC guidelines.

31 October 2023 in EP Europace
Verified
Journal Article
Open access
PDF file
ZCZhongli Chen
Zhongli Chen
XMXuan Ma
Xuan Ma
YGYuan Gao
Yuan Gao
SWSijin Wu
Sijin Wu
NXNan Xu
Nan Xu
KCKeping Chen
Keping Chen
Left bundle branch area pacing (LBBAP) is a novel approach for cardiac resynchronization therapy (CRT), but the impact of myocardial substrate on its effect is poorly understood. This study aims to assess the association of cardiac magnetic resonance (CMR)–derived scar burden and the response of CRT via LBBAP. Consecutive patients with CRT indications who underwent CMR examination and successful LBBAP-CRT were retrospectively analysed. Cardiac magnetic resonance late gadolinium enhancement was used for scar assessment. Echocardiographic reverse remodelling and composite outcomes (defined as all-cause death or heart failure hospitalization) were evaluated. The echocardiographic response was defined as a ≥15% reduction of left ventricular end-systolic volume. Among the 54 patients included, LBBAP-CRT resulted in a 74.1% response rate. The non-responders had higher global, septal, and lateral scar burden (all P < 0.001). Global, septal, and lateral scar percentage all predicted echocardiographic response [area under the curve (AUC): 0.857, 0.864, and 0.822; positive likelihood ratio (+LR): 9.859, 5.594, and 3.059; and negative likelihood ratio (−LR): 0.323, 0.233, and 0.175 respectively], which was superior to QRS morphology criteria (Strauss left bundle branch abnormality: AUC: 0.696, +LR 2.101, and −LR 0.389). After a median follow-up time of 20.3 (11.5–38.7) months, higher global, lateral and septal scar burdens were all predictive of the composite outcome (hazard ratios: 4.996, 7.019, and 4.741, respectively; P’s < 0.05). Lower scar burden was associated with higher response rate of LBBAP-CRT. The pre-procedure CMR scar evaluation provides further useful information to identify potential responders and clinical outcomes. Cardiac magnetic resonance–derived myocardial scar predicts response of cardiac resynchronization therapy via left bundle branch area pacing. Baseline electrocardiogram morphology and pre-procedural scar evaluation from cardiac magnetic resonance predict reverse remodelling after left bundle branch area pacing for cardiac resynchronization therapy. Low global, septal, and lateral scar burden helps to identify more responders on top of Strauss left bundle branch abnormality.

11 October 2025 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
XMXuan Ma
Xuan Ma
YTYun Tang
Yun Tang
XCXingrui Chen
Xingrui Chen
SYShujuan Yang
Shujuan Yang
JWJiaxin Wang
Jiaxin Wang
SZShihua Zhao
Shihua Zhao

2 January 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
ZDZhixiang Dong
Zhixiang Dong
XMXuan Ma
Xuan Ma
JWJiaxin Wang
Jiaxin Wang
SYShujuan Yang
Shujuan Yang
SYShiqin Yu
Shiqin Yu
SZShihua Zhao
Shihua Zhao
Background: Strain analysis is a sensitive method for the assessment of ventricular structural or functional alterations. The authors aimed to determine whether right ventricular (RV) strain parameters can discriminate patients with revised Task Force Criteria–diagnosed arrhythmogenic RV cardiomyopathy (ARVC) incremental to the existing cardiovascular magnetic resonance (CMR) criteria, thus improving the diagnostic yield of CMR in ARVC. Methods and Results: A total of 74 patients with revised Task Force Criteria–diagnosed ARVC (37 borderline and 37 definite) and 37 controls were retrospectively enrolled for analysis. Using CMR feature tracking, RV global longitudinal (GLS), circumferential, and radial strain of all participants were evaluated. Compared with controls, the study patients demonstrated significantly impaired global biventricular strain in all 3 directions (all P 50% presenting with impaired RV GLS. When both conventional criteria and RV GLS were considered together, this new diagnostic method demonstrated an overall diagnostic accuracy of 90%. The likelihood ratio test showed a significant incremental diagnostic value of RV GLS ( P =0.02) over the existing CMR major criteria. Conclusions: The current study showed an improved diagnostic accuracy when both RV GLS and the existing CMR criteria were considered together, especially for patients with borderline diagnosis, suggesting the incremental value of strain analysis to the initial assessment of ARVC.

1 June 2024 in Radiology: Cardiothoracic Imaging
Verified
Journal Article
Closed access
ZDZhixiang Dong
Zhixiang Dong
LDLinlin Dai
Linlin Dai
YSYanyan Song
Yanyan Song
XMXuan Ma
Xuan Ma
JWJiaxin Wang
Jiaxin Wang
SZShihua Zhao
Shihua Zhao
Right ventricular global longitudinal strain derived from cardiac MRI feature tracking demonstrated good diagnostic and prognostic value in arrhythmogenic right ventricular cardiomyopathy. Purpose To demonstrate the myocardial strain characteristics of patients with arrhythmogenic right ventricular cardiomyopathy (ARVC), based on revised Task Force Criteria (rTFC), and to explore the...

11 February 2025 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PZPengyu Zhou
Pengyu Zhou
ZDZhixiang Dong
Zhixiang Dong
XHXiaoying Hu
Xiaoying Hu
SYShujuan Yang
Shujuan Yang
JWJiaxin Wang
Jiaxin Wang
SZShihua Zhao
Shihua Zhao
Aims: This study aimed to evaluate the association between cardiac magnetic resonance imaging (CMR) multiparameters and significant acute cardiac allograft rejection (SR), and assess the incremental value of CMR multiparameters over conventional serum examinations for identifying SR. Methods and results: Heart transplantation (HTx) recipients with endomyocardial biopsy and healthy controls were prospectively recruited for CMR assessment. CMR feature tracking was performed to evaluate the left ventricular (LV) global strain in all three directions. The last serum examinations including N-terminal pro-brain natriuretic peptide (NT-proBNP) before anti-rejection therapy were recorded. Participants were divided into three groups: control, SR [acute cellular rejection grade ≥ 2R and/or antibody-mediated rejection (AMR) grade ≥ pAMR1], and NSR (non-SR). Finally, 30 controls (43.3 ± 13.6 years, 26 males) and 51 HTx recipients comprising 23 SRs (48.6 ± 12.6 years, 24 males) and 28 NSRs (42.7 ± 14.9 years, 16 males) were enrolled for analysis. Compared with NSRs, SRs showed elevated NT-proBNP (7797.0 ± 7527.6 pg/mL vs. 3334.6 ± 5935.3 pg/mL, P < 0.001), worse LV global longitudinal strain (GLS) (−9.7 ± 3.1% vs. −13.1 ± 2.9%, P < 0.001), and increased native T1 (1384 ± 80.1 ms vs. 1321 ± 69.9 ms, P < 0.001) and T2 values (50.9 ± 2.7 ms vs. 45.7 ± 4.3 ms, P < 0.001). In multivariable analysis, LVGLS (OR = 0.76, 95% CI, 0.59–0.98, P = 0.03) and T2 value (OR = 1.35, 95% CI, 1.10–1.65, P = 0.01) were independently associated with SR after NT-proBNP adjustment. Furthermore, the likelihood ratio test showed LVGLS (P = 0.002) and T2 value (P < 0.001) had incremental value over NT-proBNP for identifying SR. Conclusion: LVGLS and T2 value were independently associated with SR, providing incremental value for non-invasive identification of significant rejection in HTx recipients.